NDC 19515-818
Flulaval Quadrivalent 2021/2022
Influenza Virus Vaccine
Flulaval Quadrivalent 2021/2022 is a Intramuscular Suspension in the Vaccine category. It is labeled and distributed by Id Biomedical Corporation Of Quebec. The primary component is Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (uv, Formaldehyde Inactivated); Influenza A Virus A/tasmania/503/2020 Ivr-221 (h3n2) Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/washington/02/2019 Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (uv, Formaldehyde Inactivated).
| Product ID | 19515-818_30deaea6-2ad1-4b26-a254-84f35e1f0f81 |
| NDC | 19515-818 |
| Product Type | Vaccine |
| Proprietary Name | Flulaval Quadrivalent 2021/2022 |
| Generic Name | Influenza Virus Vaccine |
| Dosage Form | Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2021-07-02 |
| Marketing End Date | 2022-06-30 |
| Marketing Category | BLA / |
| Application Number | BLA125163 |
| Labeler Name | ID Biomedical Corporation of Quebec |
| Substance Name | INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| NDC Exclude Flag | N |